Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma

BACKGROUND: The relevance of estrogen receptor (ER) expression in pancreatic ductal adenocarcinoma (PDAC) is largely unknown. Clinical trials targeting ER with selective estrogen receptor modulators in pancreatic cancer did not show any benefit. Here, we analyze the impact of recently characterized...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Seeliger, Hendrik, Pozios, Ioannis, Assmann, Gerald, Zhao, Yue, Müller, Mario H., Knösel, Thomas, Kreis, Martin E., Bruns, Christiane J.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206939/
https://ncbi.nlm.nih.gov/pubmed/30373552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4973-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky